Stay updated on Cabozantinib Pembrolizumab Combo in Advanced Melanoma Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib Pembrolizumab Combo in Advanced Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib Pembrolizumab Combo in Advanced Melanoma Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision identifier changed from v3.7.0 to v3.7.1; the study page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-07T00:12:09.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    The page now renders a 403 Forbidden error instead of the study record content. The detailed study information and navigation have been replaced by an error page.
    Difference
    20%
    Check dated 2026-09-22T23:57:18.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Revision updated from v3.6.6 to v3.7.0 on the page, reflecting a site-wide upgrade. This change does not modify the study-specific content or data shown on the page.
    Difference
    0.1%
    Check dated 2026-09-15T23:52:50.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The page revision label has been updated to v3.6.6, indicating a minor platform update. There are no changes to study details or visible content.
    Difference
    0.1%
    Check dated 2026-09-01T19:47:20.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.5, replacing v3.6.4. This indicates a new software release of the site platform.
    Difference
    0.1%
    Check dated 2026-08-11T19:34:42.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    Revision: v3.6.4 was added and Revision: v3.6.3 was removed, indicating a platform/version update. No changes to the study details or visible content are indicated by these entries.
    Difference
    0.1%
    Check dated 2026-07-28T14:42:32.000Z thumbnail image

Stay in the know with updates to Cabozantinib Pembrolizumab Combo in Advanced Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib Pembrolizumab Combo in Advanced Melanoma Clinical Trial page.